EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

In vivo and in silico models of Drosophila for Parkinson's disease

Müberra Fatma Cesur iD, Rachel Strazdins iD, Souvarish Sarkar iD, Tunahan Çakır iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70140 ↗

At a glance

Übersichtsarbeit in The FEBS Journal, 2025. Written by Müberra Fatma Cesur and 3 co-authors. Institution: Bioinformatics and Systems Biology Program, Department of Bioengineering, Gebze Technical University, Kocaeli, Turkey. Major MEDLINE topics: Drosophila, Parkinson Disease. Cited 8 times so far (Crossref); 165 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIEHS NIH HHS, CLC NIH HHS, Clinical Center.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The fruit fly Drosophila melanogaster has emerged as an important model organism to shed light on neurodegeneration. Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, the cause of which is still mostly unclear. The long‐term use of available PD drugs may have major side effects, and they only target the symptoms without providing any effective cure for the disease. Therefore, in vivo and in silico approaches are extensively used to model PD‐like phenotypes in Drosophila and investigate cellular alterations underlying PD pathogenesis. In vivo models are particularly crucial to provide insight into the PD‐related molecular processes. It has been a preferred approach to investigate these models by collecting omics datasets, which can be further analysed using in silico modeling such as genome‐scale metabolic models and artificial intelligence applications. This review aims to summarise in vivo and in silico modeling studies in the literature to illustrate the potential of the Drosophila in the characterisation of PD‐related biological mechanisms towards providing early biomarkers and novel treatment options for PD.

Subjects

MeSH terms (MEDLINE)

DrosophilaParkinson DiseaseHumansAnimalsComputer SimulationAnimals, Genetically ModifiedTranscriptomeProteomeGenome

Author keywords

Drosophila melanogasterParkinson's diseaseartificial intelligencegenetic factorgenome‐scale metabolic modelingneurotoxinproteometranscriptome

Substances

Proteome

Authors and institutions

  • Bioinformatics and Systems Biology Program, Department of Bioengineering, Gebze Technical University, Kocaeli, Turkey.
  • Department of Environmental Medicine, University of Rochester Medical Center, NY, USA.

ORCID profiles: Müberra Fatma Cesur, Rachel Strazdins, Souvarish Sarkar, Tunahan Çakır

Funding

  • NIEHS NIH HHS
  • CLC NIH HHS
  • Clinical Center

Cite

APA

Cesur, M. F., Strazdins, R., Sarkar, S., & Çakır, T. (2025). In vivo and in silico models of Drosophila for Parkinson's disease. The FEBS Journal. https://doi.org/10.1111/febs.70140

Vancouver

Cesur MF, Strazdins R, Sarkar S, Çakır T. In vivo and in silico models of Drosophila for Parkinson's disease. The FEBS Journal. 2025. doi:10.1111/febs.70140

BibTeX
@article{Cesur2025,
  author = {Cesur, Müberra Fatma and Strazdins, Rachel and Sarkar, Souvarish and Çakır, Tunahan},
  title = {In vivo and in silico models of Drosophila for Parkinson's disease},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70140}
}
Start for free →